|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Applies inorganic mineral to absorb toxins associated with diarrhea. |
|
| Management |
| Richard M. Scruggs, President and Chief Executive Officer;Robert H. Carpenter, DVM, Chief Science Officer; H. Andrew Hansen II, MD, Central Texas Cardiovascular Surgery, Medical Director;James E. Carter, PhD
Director of Quality; Carol Cherkis, PhD, Director |
| |
|
|
| |
|
| Keywords |
| urology, mineral, diarrhea, infectious, disease, toxins, inflammatory |
|
|
|
| Description |
|
Salient is a Texas-based company formed in 2007 to explore the pharmaceutical application of its proprietary composition of a rare, all-natural mineral. This composition has been proven to adsorb a range of toxins and inflammatory proteins commonly associated with diarrhea.
Salient�s compound, CASAD�, is envisioned to be a �platform� product effective across a spectrum of conditions from Cancer Therapy-Induced Diarrhea to infectious disease and chronic GI conditions. It also has the potential to be used as a rescue agent for other drugs with toxic side effects.
The mission of Salient Pharmaceuticals is to improve health and quality of life while strengthening the odds of therapy success for patients who suffer from the
debilitating effects of chronic and/or acute diarrhea. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members